首页> 外国专利> COMPOSITIONS FOR PULMONARY DELIVERY OF LONG-ACTING MUSCARINIC ANTAGONISTS AND LONG-ACTING BETA2 ADRENERGIC RECEPTOR AGONISTS AND ASSOCIATED METHODS AND SYSTEMS

COMPOSITIONS FOR PULMONARY DELIVERY OF LONG-ACTING MUSCARINIC ANTAGONISTS AND LONG-ACTING BETA2 ADRENERGIC RECEPTOR AGONISTS AND ASSOCIATED METHODS AND SYSTEMS

机译:长效肌肉拮抗剂和长效β2肾上腺素受体激动剂的肺部给药组合物及相关方法和系统

摘要

PROBLEM TO BE SOLVED: To provide compositions, methods and systems for pulmonary delivery of long-acting muscarinic antagonists (LAMA) and long-acting β2 adrenergic receptor agonists (LABA) via a metered dose inhaler (MDI).;SOLUTION: Provided is a pharmaceutical composition comprising a suspension medium, a plurality of active agent particles selected from LAMA and LABA, and suspending particles, where the active agent particles and suspending particles form a co-suspension in the suspension medium. Also provided is a pharmaceutical composition where the active agent included in the active agent particle is a LAMA active agent selected from glycopyrrorate, dexipirronium, tiotropium, trospium, aclidinium, darotropium, and any pharmaceutically acceptable salts, esters, isomers or solvates thereof, in particular, glycopyrrorate.;SELECTED DRAWING: Figure 8;COPYRIGHT: (C)2016,JPO&INPIT
机译:解决的问题:提供通过计量吸入器(MDI)肺部递送长效毒蕈碱拮抗剂(LAMA)和长效β 2 肾上腺素能受体激动剂(LABA)的组合物,方法和系统)解决方案:提供了一种药物组合物,其包含悬浮介质,选自LAMA和LABA的多种活性剂颗粒以及悬浮颗粒,其中所述活性剂颗粒和悬浮颗粒在悬浮介质中形成共悬浮液。还提供了一种药物组合物,其中活性剂颗粒中包含的活性剂是选自格隆溴铵,右旋吡咯烷,噻托铵,托普索铵,阿地铵,da托铵的LAMA活性剂,及其任何药学上可接受的盐,酯,异构体或溶剂化物。 ,格隆溴铵。;选定的图纸:图8;版权:(C)2016,JPO&INPIT

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号